There are currently several clinical trials (NCT03658772, NCT03152370, NCT04344795, NCT04432857) investigating EP4 inhibitors for the treatment of colorectal cancer and other solid tumors, including endometrial and cervical cancers. The gene discussed is PTGER4; the disease is cervical cancer.